El-Mas Mahmoud M, Abdel-Rahman Abdel A
Department of Pharmacology, School of Medicine, East Carolina University, Greenville, NC, USA.
Toxicol Appl Pharmacol. 2015 Sep 15;287(3):284-92. doi: 10.1016/j.taap.2015.06.015. Epub 2015 Jun 23.
Evidence suggests that male rats are protected against the hypotensive and myocardial depressant effects of ethanol compared with females. We investigated whether E2 modifies the myocardial and oxidative effects of ethanol in male rats. Conscious male rats received ethanol (0.5, 1 or 1.5g/kg i.v.) 30-min after E2 (1μg/kg i.v.) or its vehicle (saline), and hearts were collected at the conclusion of hemodynamic measurements for ex vivo molecular studies. Ethanol had no effect in vehicle-treated rats, but it caused dose-related reductions in LV developed pressure (LVDP), end-diastolic pressure (LVEDP), rate of rise in LV pressure (dP/dtmax) and systolic (SBP) and diastolic (DBP) blood pressures in E2-pretreated rats. These effects were associated with elevated (i) indices of reactive oxygen species (ROS), (ii) malondialdehyde (MDA) protein adducts, and (iii) phosphorylated death-associated protein kinase-3 (DAPK3), Akt, and extracellular signal-regulated kinases (ERK1/2). Enhanced myocardial anti-oxidant enzymes (heme oxygenase-1, catalase and aldehyde dehydrogenase 2) activities were also demonstrated. In conclusion, E2 promotes ethanol-evoked myocardial oxidative stress and dysfunction in male rats. The present findings highlight the risk of developing myocardial dysfunction in men who consume alcohol while receiving E2 for specific medical conditions.
有证据表明,与雌性大鼠相比,雄性大鼠对乙醇的降压和心肌抑制作用具有抵抗力。我们研究了雌二醇(E2)是否会改变雄性大鼠乙醇的心肌和氧化作用。清醒的雄性大鼠在静脉注射E2(1μg/kg)或其溶剂(生理盐水)30分钟后,静脉注射乙醇(0.5、1或1.5g/kg),在血流动力学测量结束时收集心脏用于离体分子研究。乙醇对溶剂处理的大鼠没有影响,但在E2预处理的大鼠中,它导致左心室舒张末压(LVEDP)、左心室压力上升速率(dP/dtmax)以及收缩压(SBP)和舒张压(DBP)呈剂量相关的降低。这些影响与以下因素升高有关:(i)活性氧(ROS)指标,(ii)丙二醛(MDA)蛋白加合物,以及(iii)磷酸化的死亡相关蛋白激酶-3(DAPK3)、Akt和细胞外信号调节激酶(ERK1/2)。还证实了心肌抗氧化酶(血红素加氧酶-1、过氧化氢酶和乙醛脱氢酶2)活性增强。总之,E2会促进雄性大鼠乙醇诱发的心肌氧化应激和功能障碍。本研究结果突出了在因特定医疗状况接受E2治疗时饮酒的男性发生心肌功能障碍的风险。